News & Updates
Filter by Specialty:
Ivabradine SR improves heart function in patients with HFrEF
Once-daily treatment with sustained-release (SR) ivabradine hemisulfate, alongside optimum standard therapy, results in better heart function in patients with chronic heart failure with reduced ejection fraction (HFrEF), reports a study.
Ivabradine SR improves heart function in patients with HFrEF
08 Aug 2022
Negative attitude towards MSM living with HIV tied to low knowledge, worry about HIV
Ignorance and fear of HIV both contribute significantly to the negative attitudes towards men who have sex with men (MSM) living with the virus, suggests a study presented at the 24th International AIDS Conference (AIDS 2022) in Montreal, Canada.
Negative attitude towards MSM living with HIV tied to low knowledge, worry about HIV
08 Aug 2022
BP-lowering drug helps prevent Parkinson’s disease
Treatment with angiotensin receptor blockers (ARBs) appears to reduce the risk of Parkinson’s disease (PD) in patients newly diagnosed with hypertension, reports a recent study.
BP-lowering drug helps prevent Parkinson’s disease
08 Aug 2022
Avelumab benefit may extend to cisplatin-unfit bladder cancer patients
The anti-PD-L1 antibody avelumab demonstrated clinical activity as first-line treatment for patients with metastatic or locally advanced urothelial carcinoma who were PD-L1-positive and ineligible for cisplatin, according to findings from the ARIES trial presented at EAU 2022.
Avelumab benefit may extend to cisplatin-unfit bladder cancer patients
08 Aug 2022
What do young T1DM patients look for in ketone breath sensors?
Young patients with type 1 diabetes mellitus (T1DM) find the noninvasive nature of ketone breath sensor devices attractive, especially as compared with blood testing, according to a recent study. Still, concerns about such devices remain, including their ease of use, accuracy, and affordability.
What do young T1DM patients look for in ketone breath sensors?
08 Aug 2022
Myocardial infarction after GI bleeding ups in-hospital mortality, resource use
A diagnosis of type 1 or type 2 myocardial infarction (MI) following hospitalization for gastrointestinal bleeding (GIB) often leads to higher in-hospital mortality and resource utilization, results of a recent US study have shown.